News About: Pharm. Industry
Ilyang’s new leukemia drug shows promise
Ilyang Pharmaceutical Co. says it will carry out a Phase III clinical trial of radotinib, a new leukemia medicine.
The drug is believed to be 30 times more effective than Gleevec, a popular anti-leukemia medicine. ...
Rheumatoid arthritis market to get heated
Competition is about to heat up in the domestic rheumatoid arthritis market as Green Cross Corp. will also join the market by launching its newly developed natural drug “Shinbaro” from next month.
A 12-week study o...
Drug price cuts to corner local drugmakers
Local pharmaceutical companies have been largely dependent on producing and marketing generic drugs instead of inventing new drugs.
However, a new wave of price cuts for drugs is speculated to be imminent in Korea...
Discount stores promote selling of OTC products
With customers’ response being extremely positive, major discount stores have actively promoted more over-the-counter (OTC) drugs after they were officially allowed to be sold outside pharmacies across the country sta...
Drugmakers oppose government’s drug price cut plan
The Korea Pharmaceutical Manufacturers Association said Wednesday that it has vehemently opposed to the government’s another price cuts for generic drugs.
In a board of directors meeting, the association said that ...
Dong-A and Shanghai Zhongxi Sunve sign license agreement for Zydena
Dong-A Pharmaceutical Co. said Tuesday that it has signed an agreement with Shanghai Zhongxi Sunve Pharmaceutical Co. based in China to market Dong-A’s orally-administered udenafil product, a phosphodiesterase type 5 ...
Pharmaceutical stocks plunge on U.S. credit downgrade
Domestic drug firms have seen their stocks plummet over the past several days as retail and foreign investors have dumped shares on the U.S. credit downgrade and fears of a global economic recession.
The benchmark ...
Hanmi fosters green management culture
Hanmi Pharmaceutical Co. is taking the lead in local drug firms’ green drive by releasing six environment-friendly OTC and health products in a single package form.
The move was designed not only to support the gov...
Cell Biotech files Korean patent application for osteoporosis treatment
Cell Biotech said Tuesday it has filed a local patent application for treatment of osteoporosis.
The new drug called “Duocal” contains three species of probiotic Lacto Bacillus - Lactobacillus paracasei (LPC4), Lac...
4 prescription drugs to be reclassified into OTC medicines
The Korea Food and Drug Administration decided Monday to reclassify four prescription drugs into over-the-counter medicines that may be sold at pharmacy only – Ranitidine tablets 75 mg, hyaluronic acid eye drops, Famo...
